Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.19%83.120.9%$974.73m
KITEKite Pharma, Inc.
0.03%179.3516.1%$742.28m
CELGCelgene Corporation
0.45%144.531.1%$499.94m
AMGNAmgen Inc.
0.13%186.011.1%$483.81m
BIIBBiogen Inc.
-0.16%317.941.2%$421.67m
REGNRegeneron Pharmaceuticals, Inc.
1.47%439.102.7%$359.57m
ALNYAlnylam Pharmaceuticals, Inc
1.78%115.8310.7%$250.11m
ALXNAlexion Pharmaceuticals, Inc.
0.41%143.401.9%$229.90m
JUNOJuno Therapeutics, Inc.
-4.90%42.9314.6%$225.16m
VRTXVertex Pharmaceuticals Incorporated
-1.44%149.091.9%$208.34m
INCYIncyte Corporation
-1.22%109.502.6%$205.12m
ILMNIllumina, Inc.
-0.66%200.083.5%$158.36m
BLUEBluebird Bio, Inc.
1.12%130.1919.3%$143.03m
BMRNBioMarin Pharmaceutical Inc.
-0.81%94.184.4%$136.27m
CLVSClovis Oncology, Inc.
-2.88%76.3018.0%$132.51m

Company Profile

Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.